A synthetic peptide for use as a blocking control in assays to test for specificity of DGCR8 antibody, Alternative Names: DGCR8 control peptide, DGCR8 antibody Blocking Peptide, Anti-DGCR8 Blocking Peptide, Digeorge Syndrome Critical Region Gene 8 Blocking Peptide, C22orf12 Blocking Peptide, DGCRK6 Blocking Peptide, Gy1 Blocking Peptide
Optimal conditions should be determined by the investigator
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
缓冲液
PBS
注意事项
Avoid repeated freeze/thaw cycles.
储存条件
-20 °C
储存方法
Store at -20 °C long term.
抗原
DGCR8
(DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
背景
DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.